tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

PacBio assumed with an Overweight at JPMorgan

JPMorgan assumed coverage of PacBio with an Overweight rating and $13 price target. The analyst maintained the firm’s current rating, price target, and estimates.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on PACB:

Disclaimer & DisclosureReport an Issue

1